• A
  • |
  • A
  • Text size

AMA Therapeutic Insights

Welcome to the AMA Therapeutic Insights online CME program. These CME newsletters feature the latest treatment guidelines and prescribing data for specific disease states. Intended for primary care physicians, a new therapeutic topic is offered each quarter.

Therapeutic Insights newsletterView one-page summaries of current newsletters

Managing Acute Uncomplicated Urinary Tract Infections

Managing Erectile Dysfunction

Management of Stable COPD

Current Management of Dyslipidemia in Adults

Treatment of Tobacco Dependence
Expired for CME credit. Newsletter provided for content only.

Exacerbations of Chronic Obstructive Pulmonary Disease
Expired for CME credit. Newsletter provided for content only.

Management of Migraine in Adults
Expired for CME credit. Newsletter provided for content only.

Community-Acquired Pneumonia
Expired for CME credit. Newsletter provided for content only.

What does AMA Therapeutic Insights offer physicians?

  • Up-to-date, disease-specific prescribing data*
  • Disease demographics, co-morbidities, data on patients diagnosed and treated vs. diagnosed and not treated
  • Best practices and evidence-based therapy guidelines presented in case-study format
  • AMA PRA Category 1 Credit™
  • Integrated views of actual treatment practices for the respective disease states
  • A new disease-specific newsletter every quarter

*The AMA does not collect, compile, license, sell or have access to physician prescribing data. The prescribing data included in AMA Therapeutic Insights are provided by IMS Health and are HIPAA compliant and do not contain any patient identifiable information.

How does AMA Therapeutic Insights increase the transparency of physician prescribing data?

For the first time, physicians are given access to disease-specific prescribing data and other therapy-related information in a unique CME professional development activity. AMA Therapeutic Insights offers physicians a new opportunity to improve the quality of patient care through a greater understanding of prescribing and treatment information.

How is prescribing data used for the benefit of the public?

Prescribing data are utilized by public health agencies for a variety of purposes, including studies about drug interactions, prescribing trends, long-term effects of medications, and prevention of medical errors. Medical Researchers also use prescribing information for applications such as setting and promoting public policy, accelerating healthcare innovations, driving best clinical practice, monitoring drug safety, and clinical trial recruitment.

AMA Continuing Medical Education

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Medical Association designates each enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Principles for Web site privacy and confidentiality

If you need additional information, please contact us at tinsights@ama-assn.org or (800) 621-8335.